These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [The hemoglobins of sickle-cell blood]. ROCHE J; DERRIEN Y; GALLAIS P; ROQUES M C R Seances Soc Biol Fil; 1952 Jun; 146(11-12):889-91. PubMed ID: 12998291 [No Abstract] [Full Text] [Related]
26. Variation in the amount of hemoglobin S in a patient with sickle cell trait and megaloblastic anemia. HELLER P; YAKULIS VJ; EPSTEIN RB; FRIEDLAND S Blood; 1963 Apr; 21():479-83. PubMed ID: 13953594 [No Abstract] [Full Text] [Related]
27. Evaluation of the water environments in deoxygenated sickle cells by longitudinal and transverse water proton relaxation rates. Thompson BC; Waterman MR; Cottam GL Arch Biochem Biophys; 1975 Jan; 166(1):193-200. PubMed ID: 1122135 [No Abstract] [Full Text] [Related]
28. Sickling and Vinblastine. Ricci G; Zavagli G Biomed Pharmacother; 1983; 37(2):85-7. PubMed ID: 6616035 [TBL] [Abstract][Full Text] [Related]
29. Hematologic and clinical responses in patients with sickle cell anemia after chronic extracorporeal red cell carbamylation. Deiderich DA; Trueworthy RC; Gill P; Cader AM; Larsen WE J Clin Invest; 1976 Sep; 58(3):642-53. PubMed ID: 956392 [TBL] [Abstract][Full Text] [Related]
30. The effects of hydrazine on sickle cells. Rice-Evans C; Omorphos S; White JM Biochim Biophys Acta; 1982 Oct; 691(2):367-71. PubMed ID: 7138866 [No Abstract] [Full Text] [Related]
31. Lead screening in sickle cell disease. Tigner-Weekes L; Pegelow C; Lee S; Powars D J Pediatr; 1979 Nov; 95(5 Pt 1):738-40. PubMed ID: 490241 [No Abstract] [Full Text] [Related]
32. [Physico-chemical properties of different hemoglobins in Cooley's anemia and in sickle-cell anemia]. BERTINOTTI F; LIQUORI AM Farmaco Sci Tec; 1952; 7(5):535-6. PubMed ID: 13021179 [No Abstract] [Full Text] [Related]
33. [Discocytes and echinocytes in sickle cell anemia. Investigation by scanning electron microscope]. Bessis M; Döbler J; Mandon P Nouv Rev Fr Hematol; 1970; 10(1):63-74. PubMed ID: 4246338 [No Abstract] [Full Text] [Related]
34. Oxygen dissociation curves in sickle cell anemia and in subjects with the sickle cell trait. BECKLAKE MR; GRIFFITHS SB; McGREGOR M; GOLDMAN HI; SCHREVE JP J Clin Invest; 1955 May; 34(5):751-5. PubMed ID: 14367534 [No Abstract] [Full Text] [Related]
35. Chemical and biological aspects of the inhibition of red blood cell sickling by cyanate. Manning JM; Cerami A; Gillette PN; De Furia FG; Miller DR Adv Exp Med Biol; 1972; 28():253-60. PubMed ID: 5085171 [No Abstract] [Full Text] [Related]
36. [Hematological research in sickle cell anemia]. GATTO I; RUSSO G Boll Soc Ital Biol Sper; 1955; 31(3-4):339-41. PubMed ID: 13260499 [No Abstract] [Full Text] [Related]
37. Reversible and irreversible sickling: a distinction by electron microscopy. Bertles JF; Döbler J Blood; 1969 Jun; 33(6):884-98. PubMed ID: 5795766 [No Abstract] [Full Text] [Related]
38. Sodium and potassium alterations in red cells of patients with sicklemia. ADAMS JQ J Lab Clin Med; 1957 May; 49(5):738-44. PubMed ID: 13416732 [No Abstract] [Full Text] [Related]
39. Rapid turnover of newly-synthesized beta S chains in reticulocytes from individuals with sickle cell trait. DeSimone J; Kleve L; Longley MA; Shaeffer J Biochem Biophys Res Commun; 1974 Mar; 57(1):248-54. PubMed ID: 4828186 [No Abstract] [Full Text] [Related]
40. Unusually large von Willebrand factor multimers increase adhesion of sickle erythrocytes to human endothelial cells under controlled flow. Wick TM; Moake JL; Udden MM; Eskin SG; Sears DA; McIntire LV J Clin Invest; 1987 Sep; 80(3):905-10. PubMed ID: 3497953 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]